378 related articles for article (PubMed ID: 16818210)
21. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
[TBL] [Abstract][Full Text] [Related]
22. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
[TBL] [Abstract][Full Text] [Related]
23. Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.
Landstrom AP; Dailey-Schwartz AL; Rosenfeld JA; Yang Y; McLean MJ; Miyake CY; Valdes SO; Fan Y; Allen HD; Penny DJ; Kim JJ
Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28404607
[TBL] [Abstract][Full Text] [Related]
24. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.
Tester DJ; Ackerman MJ
J Am Coll Cardiol; 2007 Jan; 49(2):240-6. PubMed ID: 17222736
[TBL] [Abstract][Full Text] [Related]
25. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan.
Kawamura M; Ohno S; Naiki N; Nagaoka I; Dochi K; Wang Q; Hasegawa K; Kimura H; Miyamoto A; Mizusawa Y; Itoh H; Makiyama T; Sumitomo N; Ushinohama H; Oyama K; Murakoshi N; Aonuma K; Horigome H; Honda T; Yoshinaga M; Ito M; Horie M
Circ J; 2013; 77(7):1705-13. PubMed ID: 23595086
[TBL] [Abstract][Full Text] [Related]
26. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
Miyata K; Ohno S; Itoh H; Horie M
Intern Med; 2018 Jul; 57(13):1813-1817. PubMed ID: 29434162
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
Wangüemert F; Bosch Calero C; Pérez C; Campuzano O; Beltran-Alvarez P; Scornik FS; Iglesias A; Berne P; Allegue C; Ruiz Hernandez PM; Brugada J; Pérez GJ; Brugada R
Heart Rhythm; 2015 Jul; 12(7):1636-43. PubMed ID: 25814417
[TBL] [Abstract][Full Text] [Related]
28. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
[TBL] [Abstract][Full Text] [Related]
29. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
Roston TM; Guo W; Krahn AD; Wang R; Van Petegem F; Sanatani S; Chen SR; Lehman A
J Electrocardiol; 2017; 50(2):227-233. PubMed ID: 27646203
[TBL] [Abstract][Full Text] [Related]
30. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.
Jabbari J; Jabbari R; Nielsen MW; Holst AG; Nielsen JB; Haunsø S; Tfelt-Hansen J; Svendsen JH; Olesen MS
Circ Cardiovasc Genet; 2013 Oct; 6(5):481-9. PubMed ID: 24025405
[TBL] [Abstract][Full Text] [Related]
31. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
[TBL] [Abstract][Full Text] [Related]
32. Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.
Marjamaa A; Laitinen-Forsblom P; Lahtinen AM; Viitasalo M; Toivonen L; Kontula K; Swan H
BMC Med Genet; 2009 Feb; 10():12. PubMed ID: 19216760
[TBL] [Abstract][Full Text] [Related]
33. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
[TBL] [Abstract][Full Text] [Related]
34. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
Garabedian L; Verryckt A; Panzer J; De Wolf D
Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993
[TBL] [Abstract][Full Text] [Related]
35. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
Watanabe H; Knollmann BC
J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
[TBL] [Abstract][Full Text] [Related]
36. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
[TBL] [Abstract][Full Text] [Related]
37. [Recurrent syncope related to catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2-R2401H mutation].
Liu X; Li JX; Hu JZ; Shen Y; Wan R; Xiong QM; Zhou QQ; Xie JY; Jin JJ; Yan X; Yu JH; Hong K
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):39-43. PubMed ID: 28100344
[No Abstract] [Full Text] [Related]
38. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
[TBL] [Abstract][Full Text] [Related]
39. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
Duan H; Lu Y; Yan S; Qiao L; Hua Y; Li Y; Zhou K; Wang C
Medicine (Baltimore); 2018 Apr; 97(16):e0368. PubMed ID: 29668588
[TBL] [Abstract][Full Text] [Related]
40. Molecular diagnostics of catecholaminergic polymorphic ventricular tachycardia using denaturing high-performance liquid chromatography and sequencing.
Postma AV; Bhuiyan ZA; Bikker H
Methods Mol Med; 2006; 126():171-83. PubMed ID: 16930012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
